Variants in activators and downstream targets of ATM, radiation exposure, and contralateral breast cancer risk in the WECARE study

Human Mutation

Volumn 33, Issue 1, 2012, Pages 158-164

  Brooks, Jennifer D ^a   Teraoka, Sharon N ^b   Reiner, Anne S ^a   Satagopan, Jaya M ^a   Bernstein, Leslie ^c   Thomas, Duncan C ^d,t   Capanu, Marinela ^a   Stovall, Marilyn ^e,u   Smith, Susan A ^e   Wei, Shan ^f   Shore, Roy E ^g,h   Boice, John D ^i,j,p   Lynch, Charles F ^k   Mellemkjær, Lene ^l,o   Malone, Kathleen E ^m   Liang, Xiaolin ^a   Haile, Robert W ^d,t   Concannon, Patrick ^b,v   Bernstein, Jonine L ^a   Begg, Colin ^a   Orlow, Irene ^a   Klein, Robert ^a   Offit, Ken ^a   Woods, Meghan ^c   John, Esther M ⁿ   Wang, Wei ⁿ   Olsen, Jørgen H ^o   Epstein, Noemi ^m   Seminara, Daniela ^q   Knight, Julia ^r   Chiarelli, Anna ^r   Duggan, David ^s   DeWall, Jeanne ^k   Stram, Daniel ^t   Diep, Anh T ^t   Xue, Shanyan ^t   Zhou, Nianmin ^t   Ter Karapetova, Evgenia ^t   Smith, Susan ^u   Teraoka, Sharon ^v   Olson, Eric R ^v   Morrison, V Anne ^v   Navarro, Lemuel ^v   Cerosaletti, Karen M ^v   Wright, Jocyndra ^v   more..

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^f BENAROYA RESEARCH INSTITUTE   (United States)

^g NEW YORK UNIVERSITY   (United States)

^h RADIATION EFFECTS RESEARCH FOUNDATION   (Japan)

ⁱ INTERNATIONAL EPIDEMIOLOGY INSTITUTE   (United States)

^j VANDERBILT INGRAM CANCER CENTER   (United States)

^k UNIVERSITY OF IOWA   (United States)

^l INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^m USA   (United States)

ⁿ CANCER PREVENTION INSTITUTE OF CALIFORNIA   (United States)

^o DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^p VANDERBILT UNIVERSITY   (United States)

^q NATIONAL CANCER INSTITUTE   (United States)

^r MOUNT SINAI HOSPITAL   (Canada)

^s TRANSLATIONAL GENOMICS RESEARCH INSTITUTE   (United States)

^t UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^u UNIVERSITY OF TEXAS   (United States)

^v UNIVERSITY OF VIRGINIA   (United States)

more..

Author keywords

Contralateral breast cancer; DNA repair; Haplotypes; Polymorphisms; Radiation

Indexed keywords

CHECKPOINT KINASE 2; MDC1 PROTEIN; MRE11A PROTEIN; NBN PROTEIN; PROTEIN; RAD50 PROTEIN; TP53BP1 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER RISK; CONTROLLED STUDY; DNA DAMAGE; FEMALE; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MATHEMATICAL MODEL; PRIORITY JOURNAL; RADIATION DOSE; RADIATION EXPOSURE; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84863283896     PISSN: 10597794     EISSN: 10981004     Source Type: Journal    
DOI: 10.1002/humu.21604     Document Type: Article

References (34)

1. Barrett JC, Fry B, Maller J, Daly M.J. 2005. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263-265.
2. Bernstein J, Langholz B,HaileR,BernsteinL, ThomasD, StovallM,MaloneK,LynchC, Olsen J, Anton-CulverH, ShoreRE, Boice JDJr, BerkowitzG,Gatti RA,Teitelbaum S, Smith SA, Rosenstein BS, Borresen-Dale A-L, Concannon P, Thompson W.D. 2004. Study design: evaluating gene-environment interactions in the etiology of breast cancer - the WECARE study. Breast Cancer Res 6:R199-R214.
3. Bernstein JL, Haile RW, Stovall M, Boice JD, Jr, Shore RE, Langholz B, Thomas DC, Bernstein L, Lynch CF, Olsen JH,Malone KE,Mellemkjaer L, Borresen-Dale A-L, Rosenstein BS, Teraoka SN, Diep AT, Smith SA, Capanu M, Reiner AS, Liang X, GattiRA,Concannon P., the WECARE Study Collaborative Group. 2010. Radiation exposure, the ATM gene, and contralateral breast cancer in the women's environmental cancer and radiation epidemiology study. J Natl Cancer Inst 102:475-483.
4. Bertelsen L, Bernstein L, Olsen JH, Mellemkjaer L, Haile RW, Lynch CF, Malone KE, Anton-Culver H, Christensen J, Langholz B, Thomas DC, Begg CB, Capanu M, Ejlertsen B, Stovall M, Boice J.D. Jr., Shore RE, Bernstein J.L., The Women's Environment, Cancer Radiation Epidemiology Study Collaborative Group. 2008. Effect of systemic adjuvant treatment on risk for contralateral breast cancer in the women's environment, cancer and radiation epidemiology study. J Natl Cancer Inst 100:32-40.
5. Boice Jr J.D. 2001. Radiation and breast carcinogenesis. Med Pediatr Oncol 36:508-513.
6. Boice Jr JD, Harvey E, Blethner M, StovallM, Flannery J. 1992. Cancer in the contralateral breast after radiotherapy for breast cancer. N Engl J Med 326:781-785.
7. Broeks A, Braaf L,Huseinovic A,Nooijen A,Urbanus J,Hogervorst F, Schmidt M, Klijn J, Russell N, Van Leeuwen F, Van't Veer L. 2007. Identification of women with an increased risk of developing radiation-induced breast cancer: a case only study. Breast Cancer Res 9:R26.
8. Cerosaletti K, Concannon P. 2004. Independent roles for Nibrin and Mre11-Rad50 in the activation and function of Atm. J Biol Chem 279:38813-38819.
9. Chen Y, ThompsonW, Semenciw R,Mao Y. 1999. Epidemiology of contralateral breast cancer. Cancer Epidemiol Biomarkers Prev 8:855-861.
10. Concannon P, Haile RW, Borresen-Dale A-L, Rosenstein BS, Gatti RA, Teraoka SN, Diep AT, Jansen L, Atencio DP, Langholz B, CapanuM, Liang X, Begg CB, Thomas DC, Bernstein L, Olsen JH,Malone KE, Lynch CF, Anton-Culver H, Bernstein JL, for the Women's Environment, Cancer, Radiation Epidemiology Study Collaborative Group. 2008. Variants in the ATM gene associated with a reduced risk of contralateral breast cancer. Cancer Res 68:6486-6491.
11. Conneely KN, Boehnke M. 2007. So many correlated tests, so little time! rapid adjustment of P values for multiple correlated tests. Am J Hum Genet 81:1158-1168.
12. Dzikiewicz-Krawczyk A. 2008. The importance of making ends meet: mutations in genes and altered expression of proteins of the MRN complex and cancer. Mutat Res 659:262-273.
13. Excoffier L, Slatkin M. 1995. Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Mol Biol Evol 12:921-927.
14. Gabriel SB, Schaffner SF,NguyenH,Moore JM,Roy J, BlumenstielB,Higgins J,DeFelice M,LochnerA, FaggartM,Liu-CorderoSN,RotimiC,AdeyemoA, CooperR,Ward R, Lander ES, Daly MJ, Altshuler D. 2002. The structure of haplotype blocks in the human genome. Science 296:2225-2229.
15. Helleday T, Petermann E, Lundin C, Hodgson B, Sharma RA. 2008. DNA repair pathways as targets for cancer therapy. Nat Rev Cancer 8:193-204.
16. Hooning MJ, Aleman BMP, Hauptmann M, Baaijens MHA, Klijn JGM, Noyon R, StovallM, van Leeuwen FE. 2008. Roles of radiotherapy and chemotherapy in the development of contralateral breast cancer. J Clin Oncol 26:5561-5568.
17. Jazayeri A, Balestrini A, Garner E, Haber JE, Costanzo V. 2008. Mre11-Rad50-Nbs1-dependent processing of DNA breaks generates oligonucleotides that stimulate ATM activity. EMBO J 27:1953-1962.
18. Kraft P, Cox DG, Paynter RA, Hunter D, Vivo ID. 2005. Accounting for haplotype uncertainty in matched association studies: a comparison of simple and flexible techniques. Genet Epidemiol 28:261-272.
19. Land C, Tokunaga M, Koyama K, Soda M, Preston D, Nishimori I, Tokuoka S. 2003. Incidence of female breast cancer among atomic bomb survivors, Hiroshima and Nagasaki, 1950-1990. Radiat Res 160:707-717.
20. Lavin MF. 2008. Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer. Nat Rev Mol Cell Biol 9:759-769.
21. Lee J-H,Goodarzi AA, Jeggo PA, Paull TT. 2010. 53BP1 promotes ATMactivity through direct interactions with the MRN complex. EMBO J 29:574-585.
22. Lee J-H, Paull TT. 2004. Direct activation of the ATM protein kinase by the Mre11/Rad50/Nbs1 complex. Science 304:93-96.
23. Lee J-H, Paull TT. 2005. ATM activation by DNA double-strand breaks through the Mre11-Rad50-Nbs1 complex. Science 308:551-554.
24. Luo G, Yao MS, Bender CF,MillsM, Bladl AR, Bradley A, Petrini JHJ. 1999. Disruption of mRad50 causes embryonic stem cell lethality, abnormal embryonic development, and sensitivity to ionizing radiation. Proc Natl Acad Sci USA 96:7376-7381.
25. Mellemkjaer L, Dahl C, Olsen JH, Bertelsen L, Guldberg P, Christensen J, Borresen-Dale AL, Stovall M, Langholz B, Bernstein L, Lynch CF, Malone KE, Haile RW, Andersson M, Thomas DC, Concannon P, Capanu M, Boice JD Jr, Bernstein JL. 2008. Risk for contralateral breast cancer among carriers of the CHEK2*1100delC mutation in theWECARE Study. Br J Cancer 98:728-733.
26. Millikan RC, Player JS, deCotret AR, Tse C-K, Keku T. 2005. Polymorphisms in DNA repair genes, medical exposure to ionizing radiation, and breast cancer risk.Cancer Epidemiol Biomarkers Prev 14:2326-2334.
27. PrestonDL,Mattsson A,Holmberg E, Shore R,Hildreth N, Boice Jr JD. 2002. Radiation effects on breast cancer risk: a pooled analysis of eight cohorts Radiat Res 158:220-235.
28. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MAR, Bender D, Maller J, Sklar P, de Bakker PIW, Daly MJ, Sham PC. 2007. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81:559-575.
29. Ripperger T,GadzickiD,Meindl A, Schlegelberger B. 2008. Breast cancer susceptibility: current knowledge and implications for genetic counselling. Eur J Hum Genet 17:722-731.
30. Stovall M, Smith SA, Langholz BM, Boice Jr JD, Shore RE, Andersson M, Buchholz TA, Capanu M, Bernstein L, Lynch CF, Malone KE, Anton-Culver H, Haile RW, Rosenstein BS, Reiner AS, Thomas DC, Bernstein JL. 2008. Dose to the contralateral breast from radiotherapy and risk of second primary breast cancer in the WECARE study. Int J Radiat Oncol Biol Phys 72:1021-1030.
31. Thompson D, Easton D. 2004. The genetic epidemiology of breast cancer genes. J Mammary Gland Biol Neoplasia 9:221-236.
32. Waltes R, Kalb R, Gatei M, Kijas AW, Stumm M, Sobeck A, Wieland B, Varon R, Lerenthal Y, Lavin MF, Schindler D, D̈ork T. 2009. Human RAD50 deficiency in a Nijmegen breakage syndrome-like disorder. Am J Hum Genet 84:605-616.
33. Williams R,Williams J, Tainer J. 2007. Mre11-Rad50-Nbs1 is a keystone complex connecting DNA repairmachinery, double-strand break signaling, and the chromatin template. Biochem Cell Biol 85:509-520.
34. Zhong H, Bryson A, Eckersdorff M, Ferguson DO. 2005. Rad50 depletion impacts upon ATR-dependent DNA damage responses. Hum Mol Genet 14:2685-2693